Exorex have formulated the following range of products to effectively manage mild-to-moderate psoriasis:
Product name: Exorex Lotion 5% v/w Cutaneous Emulsion
Active Ingredients: Coal tar solution 5% v/w
Indications: Exorex is for the treatment of psoriasis of the skin and scalp.
Legal Category: GSL
Further information is available from: www.tevauk.com. Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at:
Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard
Adverse events should also be reported to www.tevauk.com/contact-us
Exorex Moisturising Cream
Exorex Hair & Body Shampoo
Exorex Lotion is central to the Exorex Management System. The formula contains prepared coal tar in a base of esterified essential fatty acids.
Exorex Lotion is a clinically proven treatment, shown to provide:
- effective treatment when compared to a conventional coal tar lotion and a frequently-prescribed vitamin D analogue1,2
- a 70% improvement in the signs and symptoms of psoriasis over a 12-week period1
- fewer application-site reactions, plus added patient acceptability1
- a logical, first-line therapeutic option for mild-to-moderate psoriasis11Goodfield M, Kownacki S, Berth-Jones J. Double-blind, randomised multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis. J Dermatol Treat 2003;14:1-9
1Goodfield M, Kownacki S, Berth-Jones J. Double-blind, randomised multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis. J Dermatol Treat 2003;14:1-9
2Tzaneva S, Hönigsmann H, Tanew A. Observer-blind, randomised intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis. Br J Dermatol 2003;149:350-353
Disclaimer: Exorex Lotion has not changed since these clinical trials, but in line with regulatory concerns the active is now listed as ‘5% coal tar solution’.
Always Read The Label.